$88.45
-0.690 (-0.774%)
At Close: Jun 03, 2026
3 No-Brainer Stocks to Buy for Under $100 Right Now
06:50am, Saturday, 28'th Oct 2023
AstraZeneca's slump presents a great buying opportunity. BioNTech's future prospects go well beyond COVID-19.
7 Undervalued Stocks That Analysts Love Right Now
02:50pm, Thursday, 26'th Oct 2023
Ahead of possible volatility in the market, investors may find some measure of confidence in undervalued stocks. From a psychological perspective, companies that sit well outside the well-beaten path
Pfizer and BioNTech announce positive data in early trial of flu/COVID combination vaccine
07:00am, Thursday, 26'th Oct 2023
Pfizer Inc. PFE and German partner BioNTEch SE BNTX announced positive results from a Phase 1/2 trial of their combined mRNA flu/COVID vaccine on Thursday in adults aged 18 to 64. The vaccine candidat
Pfizer, BioNtech say flu-COVID shot generates immune response
06:53am, Thursday, 26'th Oct 2023
Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against the virus strains in early- to mid-stage trials.
Is BioNTech Stock a Buy Now?
07:00am, Wednesday, 25'th Oct 2023
BioNTech's coronavirus portfolio isn't doing as well as last year. The company has a rich pipeline, but few of its products are in late-stage studies.
MAINZ, Germany , October 23, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2023 on Monday, Novembe
7 Stocks That Are Heading for a Train Wreck
09:59am, Thursday, 19'th Oct 2023
One of the big slogans favored by CNBC pundit Jim Cramer is, “There's always a bull market somewhere.” I believe that's true.
Paxlovid contract renegotiation pushed Covid business over the edge, says BMO's Evan Seigerman
06:11pm, Monday, 16'th Oct 2023
Evan Seigerman, BMO Capital Markets analyst, joins 'Closing Bell: Overtime' to discuss Pfizer and BioNTech cutting guidance amid Covid sales falling, the weight loss boom, and more.
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand
07:18am, Monday, 16'th Oct 2023
Pfizer slashed its revenue forecasts on Friday amid falling demand for its Covid vaccine and antiviral drug Paxlovid.
Pfizer and BioNtech take big write-downs on Covid jab stocks
06:21am, Monday, 16'th Oct 2023
Covid vaccine developer BioNTech is to take a write-down of up to €900 million on its stocks of jabs following a similar provision by partner Pfizer last week. Pfizer had said that the write-offs r
Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move
06:10am, Monday, 16'th Oct 2023
Shares of Lululemon Athletica Inc. LULU, +1.00% rallied more than 5% after index provider S&P Dow Jones Indices said the stock will join the S&P 500 index SPX on Wednesday.
BioNTech will likely take 900 mln eur write-off on Pfizer-partnered vaccines
03:59am, Monday, 16'th Oct 2023
Germany's BioNTech on Monday said it would likely take write-downs of up to 900 million euros ($947 million) in the third quarter after its partner Pfizer reported similar charges on their COVID-19 va
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
03:30am, Monday, 16'th Oct 2023
MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data across its oncology pipeline, covering multiple solid tumor types and novel mecha
7 Innovator Stocks Primed for Exceptional Growth
06:46pm, Tuesday, 10'th Oct 2023
Artificial intelligence. New pharmaceutical drugs.
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street
05:52am, Sunday, 01'st Oct 2023
BioNTech's pipeline is loaded with promising candidates. PayPal Holdings is dirt cheap and is delivering solid earnings growth.
Sign In
Buy BNTX